Why the Bionomics share price has rebounded 75% in 2019

The Bionomics Ltd (ASX: BNO) share price is up from 11 cents to 19 cents over the course of 2019, but is still down around 66% since April 2018 when the stock changed hands for more than 60 cents.

Bionomics is a pharmaceutical or biotechnology business conducting clinical trials into drugs that could help treat central nervous system disorders such as post traumatic stress, anxiety, and depression.

However, on October 2 the company’s share price crashed around 68% in a single day after it admitted a clinical trial for its BNC210 drug to treat post traumatic stress disorder failed to meet its clinical endpoint.

However, the company is ploughing ahead with trials into its BNC210 drug to treat “elderly patients suffering from agitation” with the results expected in the first quarter of 2019.

For the quarter ending December 31 2018 it posted cash receipt of $2.66 million and had cash on hand of $27.35 million. The stock price is probably rising in hope of more promising trial results.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!